105 related articles for article (PubMed ID: 2788421)
1. [Catalytic biotransformation of physiologically active 1-methyl-4- aryl-1,2,3,6-tetrahydropyridines under the action of monoaminooxidase].
Bachurin SO; Sablin SO; Grishina GV; Gaĭdarova EL; Dubova DG
Bioorg Khim; 1989 May; 15(5):620-6. PubMed ID: 2788421
[TBL] [Abstract][Full Text] [Related]
2. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
[TBL] [Abstract][Full Text] [Related]
3. Studies on the monoamine oxidase-B-catalyzed biotransformation of 4-azaaryl-1-methyl-1,2,3,6-tetrahydropyridine derivatives.
Nimkar SK; Mabic S; Anderson AH; Palmer SL; Graham TH; de Jonge M; Hazelwood L; Hislop SJ; Castagnoli N
J Med Chem; 1999 May; 42(10):1828-35. PubMed ID: 10346935
[TBL] [Abstract][Full Text] [Related]
4. [The structure-activity relationship in the dehydrogenation processes of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogs under the action of MAO].
Sablin SO; Tkachenko SE; Bachurin SO
Dokl Akad Nauk SSSR; 1991; 318(1):228-31. PubMed ID: 1893833
[No Abstract] [Full Text] [Related]
5. Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Mabic S; Castagnoli N
J Med Chem; 1996 Sep; 39(19):3694-700. PubMed ID: 8809158
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.
Nimkar SK; Anderson AH; Rimoldi JM; Stanton M; Castagnoli KP; Mabic S; Wang YX; Castagnoli N
Chem Res Toxicol; 1996 Sep; 9(6):1013-22. PubMed ID: 8870990
[TBL] [Abstract][Full Text] [Related]
7. The role of MAO in MPTP toxicity--a review.
Glover V; Gibb C; Sandler M
J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
[TBL] [Abstract][Full Text] [Related]
8. Deuterium isotope effect studies on the MAO-B catalyzed oxidation of 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine.
Anderson AH; Kuttab S; Castagnoli N
Biochemistry; 1996 Mar; 35(10):3335-40. PubMed ID: 8605171
[TBL] [Abstract][Full Text] [Related]
9. [Derivatives of 4-phenylpiperidine as substrates of rat brain monoamine oxidase].
Ishkov AG; Ermakov NV; Mikerov SV; Kliatskiĭ IuIu; Miroshnichenko EV
Vopr Med Khim; 1992; 38(2):25-8. PubMed ID: 1413624
[TBL] [Abstract][Full Text] [Related]
10. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
12. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
Corsini GU; Pintus S; Bocchetta A; Piccardi MP; Del Zompo M
J Pharmacol Exp Ther; 1986 Aug; 238(2):648-52. PubMed ID: 3488394
[TBL] [Abstract][Full Text] [Related]
13. Stylbasole analogues of MPTP as monoamine oxidase (MAO) substrates.
Sablin SO; Bachurin SO; Tkachenko SE
J Neural Transm Suppl; 1990; 32():119-22. PubMed ID: 2089080
[TBL] [Abstract][Full Text] [Related]
14. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637
[TBL] [Abstract][Full Text] [Related]
15. Selegiline and the prophylaxis of Parkinson's disease.
Sandler M; Willoughby J; Glover V; Gibb C
J Neural Transm Suppl; 1987; 25():35-43. PubMed ID: 3123604
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and MAO-B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines.
Yu J; Castagnoli N
Bioorg Med Chem; 1999 Feb; 7(2):231-9. PubMed ID: 10218814
[TBL] [Abstract][Full Text] [Related]
17. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Fuller RW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.
Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B.
Gessner W; Brossi A; Bembenek ME; Fritz RR; Abell CW
FEBS Lett; 1986 Apr; 199(1):100-2. PubMed ID: 3485542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
